SLI
|
2 110,78
|
-10,79
|
-0,51%
|
Analysen zu SLI-Werten
| 13.01.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 10.01.25 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.01.25 | Richemont Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.01.25 | ABB Sector Perform | RBC Capital Markets | |
| 10.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 09.01.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 09.01.25 | Richemont Sector Perform | RBC Capital Markets | |
| 08.01.25 | Nestlé Market-Perform | Bernstein Research | |
| 08.01.25 | UBS Hold | Deutsche Bank AG | |
| 08.01.25 | Nestlé Underperform | Jefferies & Company Inc. | |
| 07.01.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 07.01.25 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.01.25 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.01.25 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.01.25 | Roche Outperform | Bernstein Research | |
| 07.01.25 | Novartis Outperform | Bernstein Research | |
| 06.01.25 | ABB Hold | Jefferies & Company Inc. | |
| 06.01.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 06.01.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 06.01.25 | UBS Outperform | RBC Capital Markets | |
| 06.01.25 | Givaudan Neutral | UBS AG | |
| 06.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 06.01.25 | ABB Sell | Deutsche Bank AG | |
| 06.01.25 | ABB Underperform | Bernstein Research | |
| 03.01.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 02.01.25 | Richemont Buy | UBS AG | |
| 30.12.24 | Nestlé Market-Perform | Bernstein Research | |
| 27.12.24 | UBS Outperform | RBC Capital Markets | |
| 27.12.24 | Nestlé Market-Perform | Bernstein Research | |
| 19.12.24 | ABB Neutral | UBS AG | |
| 19.12.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 19.12.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 19.12.24 | Zurich Insurance Sell | UBS AG | |
| 18.12.24 | ABB Market-Perform | Bernstein Research | |
| 18.12.24 | Givaudan Hold | Deutsche Bank AG | |
| 18.12.24 | Givaudan Neutral | UBS AG | |
| 18.12.24 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 17.12.24 | Novartis Hold | Deutsche Bank AG | |
| 17.12.24 | Nestlé Buy | Goldman Sachs Group Inc. | |
| 17.12.24 | Swiss Re Neutral | Goldman Sachs Group Inc. |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.